Old Web
English
Sign In
Acemap
>
Paper
>
THE RISK OF COVID-19 SEVERITY IN PATIENTS WITH MS APPEARS TO BE ASSOCIATED WITH IMMUNOTHERAPY
THE RISK OF COVID-19 SEVERITY IN PATIENTS WITH MS APPEARS TO BE ASSOCIATED WITH IMMUNOTHERAPY
2021
E. Iacobaeus
Inger Boström
Ch. Zhukovsky
Sh.G. Berntsson
Anne-Marie Landtblom
Keywords:
Oncology
Coronavirus disease 2019
Immunotherapy
in patient
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]